AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
NALBUPHINE
6 registrations across 4 African markets— 5 active
Markets with NALBUPHINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Nubin Injection 20mg/ml Injection | 🇰🇪Kenya | The Searle Company Ltd | active | Jan 2027 |
| Nubin Injection 10mg/ml Injection | 🇰🇪Kenya | The Searle Company Ltd | active | Jan 2027 |
| NALBUPHINE AGUETTANT Solution injectable / 20mg /2ml | 🇹🇳Tunisia | LABORATOIRE AGUETTANT | expired | May 2010 |
| RUBUPHINE 20 mg Solution for injection | 🇹🇿Tanzania | Rusan Pharma Limited | active | — |
| RUBUPHINE 10 mg Solution for injection | 🇹🇿Tanzania | Rusan Pharma Limited | active | — |
| NALBUPHINE AGUETTANT solution injectable / 20 mg / 2 ml | 🇸🇳Senegal | AGUETTANT | active | — |
NALBUPHINE in Africa — Regulatory Overview
NALBUPHINE is registered across 4 African markets with 6 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Tanzania, Senegal, Tunisia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 6 registrations, 5 (83%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.